Literature DB >> 26487217

Laparoscopic translevator approach to abdominoperineal resection for rectal adenocarcinoma: feasibility and short-term oncologic outcomes.

Vanessa N Palter1, Steven MacLellan2,3, Shady Ashamalla2,4.   

Abstract

BACKGROUND: The extra-levator approach to abdominal perineal resection (APR) was developed in order to reduce the rates of positive circumferential resection margin. This approach, however, is associated with significant morbidity. We postulate that a less radical resection of the levators done laparoscopically could significantly decrease the rate of perineal complications while ensuring an oncologically adequate specimen. To date, to our knowledge, there are no reports in the literature describing a laparoscopic translevator approach for APR. The purpose of this study is to describe our initial experience with this approach and assess our short-term oncologic and clinical outcomes.
METHODS: This is a retrospective study of patients who underwent laparoscopic APR with intra-abdominal levator transection for rectal cancer from 2012 to 2014 at a single tertiary care institution. Main outcome measures include: perineal flap rates, post-operative complications, length of stay, distance from tumour to circumferential resection margin, R0 status, and disease recurrence. Data are presented as median (interquartile range) unless otherwise noted.
RESULTS: Seventeen cases were identified. Patient age was 61 (range 34-75), and 59 % were male. Pre-operative distance of the tumour from the anal verge was 2.6 cm (0.4-3.9). Post-operative length of stay was 4 (4-6) days. One patient required a perineal flap for reconstruction. Four patients (22 %) had perineal complications (three wound infections and one hernia). No patients reported sexual dysfunction, and one (5 %) developed urinary retention. Five (29 %) patients had a complete pathological response. The circumferential resection margin was 1.5 (0.8-2.5) cm, with no positive margins reported. The number of retrieved lymph nodes was 12 (range 2-30). Follow-up was 9.7 months (range 20 days-23 months), during which one patient developed recurrent disease.
CONCLUSIONS: This study describes a novel surgical approach to APR that has the potential to both decrease perineal complications and provide excellent oncologic results.

Entities:  

Keywords:  Laparoscopic abdominal perineal resection; Perineal wound complications; Translevator approach

Mesh:

Year:  2015        PMID: 26487217     DOI: 10.1007/s00464-015-4589-8

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  31 in total

1.  Oncological outcome after laparoscopic abdominoperineal excision of the rectum.

Authors:  M T Jefferies; M D Evans; J Hilton; T V Chandrasekaran; J Beynon; U Khot
Journal:  Colorectal Dis       Date:  2012-08       Impact factor: 3.788

2.  Oncological superiority of extralevator abdominoperineal resection over conventional abdominoperineal resection: a meta-analysis.

Authors:  Ao Huang; Hongchao Zhao; Tianlong Ling; Yingjun Quan; Minhua Zheng; Bo Feng
Journal:  Int J Colorectal Dis       Date:  2014-01-03       Impact factor: 2.571

3.  Low rectal cancer: a call for a change of approach in abdominoperineal resection.

Authors:  Iris D Nagtegaal; Cornelius J H van de Velde; Corrie A M Marijnen; Jan H J M van Krieken; Philip Quirke
Journal:  J Clin Oncol       Date:  2005-12-20       Impact factor: 44.544

4.  Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer.

Authors:  T Holm; A Ljung; T Häggmark; G Jurell; J Lagergren
Journal:  Br J Surg       Date:  2007-02       Impact factor: 6.939

5.  Multicentre study of circumferential margin positivity and outcomes following abdominoperineal excision for rectal cancer.

Authors:  R P Kennelly; A C Rogers; D C Winter
Journal:  Br J Surg       Date:  2012-11-12       Impact factor: 6.939

Review 6.  Extended abdominoperineal excision vs. standard abdominoperineal excision in rectal cancer--a systematic overview.

Authors:  Sigmar Stelzner; Carsta Koehler; Juliane Stelzer; Anja Sims; Helmut Witzigmann
Journal:  Int J Colorectal Dis       Date:  2011-05-21       Impact factor: 2.571

7.  Circumferential resection margin involvement after laparoscopic abdominoperineal excision for rectal cancer.

Authors:  I Raftopoulos; J F Reed; R Bergamaschi
Journal:  Colorectal Dis       Date:  2012-04       Impact factor: 3.788

8.  Effect of the circumferential resection margin on survival following rectal cancer surgery.

Authors:  S B Kelly; S J Mills; D M Bradburn; A A Ratcliffe; D W Borowski
Journal:  Br J Surg       Date:  2011-01-25       Impact factor: 6.939

9.  Robotic cylindrical abdominoperineal resection with transabdominal levator transection.

Authors:  Slawomir J Marecik; Marek Zawadzki; Ashwin L Desouza; John J Park; Herand Abcarian; Leela M Prasad
Journal:  Dis Colon Rectum       Date:  2011-10       Impact factor: 4.585

10.  Evidence of the oncologic superiority of cylindrical abdominoperineal excision for low rectal cancer.

Authors:  Nicholas P West; Paul J Finan; Claes Anderin; Johan Lindholm; Torbjorn Holm; Philip Quirke
Journal:  J Clin Oncol       Date:  2008-06-09       Impact factor: 44.544

View more
  2 in total

Review 1.  A systematic review of transabdominal levator division during abdominoperineal excision of the rectum (APER).

Authors:  D L H Baird; C Simillis; C Kontovounisios; Q Sheng; S Nikolaou; W L Law; S Rasheed; P P Tekkis
Journal:  Tech Coloproctol       Date:  2017-09-11       Impact factor: 3.781

2.  Disease-free Survival and Local Recurrence for Laparoscopic Resection Compared With Open Resection of Stage II to III Rectal Cancer: Follow-up Results of the ACOSOG Z6051 Randomized Controlled Trial.

Authors:  James Fleshman; Megan E Branda; Daniel J Sargent; Anne Marie Boller; Virgilio V George; Maher A Abbas; Walter R Peters; Dipen C Maun; George J Chang; Alan Herline; Alessandro Fichera; Matthew G Mutch; Steven D Wexner; Mark H Whiteford; John Marks; Elisa Birnbaum; David A Margolin; David W Larson; Peter W Marcello; Mitchell C Posner; Thomas E Read; John R T Monson; Sherry M Wren; Peter W T Pisters; Heidi Nelson
Journal:  Ann Surg       Date:  2019-04       Impact factor: 12.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.